Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance.
Ribes D, Hachem HEL, Oberic L, Vergez F, Delas A, Belliere J, Protin C, Kamar N, Ferrandiz I, Tavitian S, Laurent C, Huart A, Chauveau D, Ysebaert L, Faguer S.
Ribes D, et al. Among authors: chauveau d.
Am J Hematol. 2018 Mar;93(3):356-362. doi: 10.1002/ajh.24984. Epub 2017 Dec 6.
Am J Hematol. 2018.
PMID: 29168251
Free article.